Rapid payer research to inform investment decisions in diabetic macular edema
Cost-effectiveness model to inform investment decisions in diabetic macular edema
Mixed treatment comparison for treatment of patients with wet age-related macular degeneration
Burden of blindness study on inherited retinal degenerations
Survey protocol for a burden of blindness study
Development and validation of a screener and QoL module in macular degeneration
Burden of illness in wet age-related macular degeneration in Japan
Literature review of visual function literature to support the National Eye Institute Visual Function Questionnaire (NEI-VFQ) in age-related macular degeneration
Cross-sectional burden of illness study for age-related macular degeneration
FDA claim strategy and endpoint review of a visual function questionnaire in age-related macular degeneration and diabetic macular edema
Content validation of a visual function questionnaire in diabetic macular edema
Slides to outline the intravitreal injection process in the UK
Healthcare resource costing study for dry eye disease in the UK
Two mini value dossiers in glaucoma
Value messages and objection handlers for anti-vascular endothelial growth factor therapy (anti-VEGF) treatment in diabetic retinopathy and retinopathy of prematurity
Utility study feasibility assessment in retinitis pigmentosis
Health utilities in thyroid disease induced proptosis and diplopia
Exploratory analysis of phase II clinical trial data for acute optic neuritis
Manuscript on health-related quality of life trial results of a new lens
Analysis of focus group results in post-Lasik corneal sensitivity
Development and validation of a pterygium instrument
Development of a briefing document on a visual function questionnaire
PRO review of the subjective eyelid swelling scale for patients with eyelid swelling upon awakening in the morning
Analysis and reporting on completed interviews about eyelid swelling
Literature review of retinopathy of prematurity
Review of PRO measures in diabetic macular edema
Development of a PRO measure to assess impacts of full eye rejuvenation
Review of evidence requirements in uveitis for national and local reimbursement submissions in five European countries, with reviews of local language guidance
Strategic consultancy meeting on uveitis
Core value dossier in uveitis
Core value dossier in paediatric uveitis
Development of a HEOR strategy for uveitis
Structured literature review and value dossier updates in a biosimilar for uveitis
Payer value deck for a biosimilar in uveitis
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsRead MoreACCEPTREJECT
Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
We’d like to set analytic software i.e. Google Analytics/Click Dimensions to help us improve our website by collecting and reporting information on how you use it. The cookies collect information in a way that does not directly identify anyone. For more information on how these cookies work, please see our Cookies Policy.